l-tyrosine
PolandDrugs containing this active substance
-
The medicinal product is administered intravenously to provide nutrients to adults and children in situations where oral nutrition is inappropriate.
Form: solution for infusion
Active substance Dosage leucine 7.3 g/l phenylalanine 5.6 g/l l-methionine 4 g/l l-lysine 5.8 g/l l-isoleucine 6 g/l l-valine 5.8 g/l l-histidine 4.8 g/l l-threonine 4.2 g/l l-tryptophan 1.8 g/l l-alanine 20.7 g/l l-arginine 11.5 g/l glycine 10.3 g/l l-prolinum 6.8 g/l l-serine 5 g/l l-tyrosine 0.4 g/l sodium acetate trihydrate 6.8 g/l potassium hydrogen phosphate 5.22 g/l sodium chloride 1.18 g/l magnesium chloride hexahydrate 1.02 g/l glucose 350 g/l calcium chloride dihydrate 0.66 g/l ATC: B05BA
Manufacturer: Baxter S.A.
-
It is an infusion solution administered intravenously to provide nutrients to adults and children in situations where oral nutrition is inappropriate.
Form: solution for infusion
Active substance Dosage leucine 4.02 g/l l-phenylalanine 3.08 g/l l-methionine 2.2 g/l l-lysine 3.19 g/l l-isoleucine 3.3 g/l l-valine 3.19 g/l l-histidine 2.64 g/l l-threonine 2.31 g/l l-tryptophan 0.99 g/l l-alanine 11.39 g/l l-arginine 6.33 g/l glycine 5.67 g/l l-prolinum 3.74 g/l l-serine 2.75 g/l l-tyrosine 0.22 g/l sodium acetate trihydrate 4.31 g/l potassium hydrogen phosphate 5.22 g/l sodium chloride 2.24 g/l magnesium chloride hexahydrate 1.02 g/l glucose 150 g/l calcium chloride dihydrate 165 g/l ATC: B05BA
Manufacturer: Baxter S.A.
-
The medicinal product is used in nutritional therapy in adult patients with chronic kidney disease (renal failure). It helps to prevent and treat the effects of abnormal or insufficient protein metabolism, provided that a restricted protein diet (40 g per day or less) is followed.
Form: tablets, film-coated
Active substance Dosage l-lysine acetate 105 mg l-threonine 53 mg l-tryptophan 23 mg l-histidine 38 mg l-tyrosine 30 mg ATC: B05A
Manufacturer: Labesfal, Laboratorios Almiro S.A.
-
The medicinal product is a source of amino acids used in parenteral nutrition. It is intended for patients with renal failure for whom oral or enteral feeding is impossible, insufficient, or contraindicated. It can also be used in patients undergoing dialysis.
Form: solution for infusion
Active substance Dosage l-isoleucine 5.8 g/1000 ml l-leucine 12.8 g/1000 ml l-lysine acetate 16.9 g/1000 ml l-methionine 2 g/1000 ml l-phenylalanine 3.5 g/1000 ml l-threonine 8.2 g/1000 ml l-tryptophan 3 g/1000 ml l-valine 8.7 g/1000 ml l-arginine 8.2 g/1000 ml l-histidine 9.8 g/1000 ml l-alanine 6.2 g/1000 ml n-acetyl-l-cysteine 0.54 g/1000 ml glycine 5.31 g/1000 ml l-prolinum 3 g/1000 ml l-serine 7.6 g/1000 ml l-tyrosine 0.6 g/1000 ml ATC: B05BA01
Manufacturer: Fresenius Kabi Austria GmbH
-
It is intended for children, infants, and neonates (including preterm infants) to provide them with protein directly into the bloodstream (intravenously) when they cannot take food orally or through the gastrointestinal tract.
Form: solution for infusion
Active substance Dosage l-isoleucine 0.67 g l-leucine 1 g l-valine 0.76 g l-lysine 1.1 g l-methionine 0.24 g l-phenylalanine 0.42 g l-threonine 0.37 g l-tryptophan 0.2 g l-arginine 0.84 g l-histidine 0.38 g l-alanine 0.8 g l-aspartic acid 0.6 g l-cysteine 0.189 g glutamic acid 1 g glycine 0.4 g l-prolinum 0.3 g l-serine 0.4 g l-tyrosine 0.045 g l-ornithine hydrochloride 0.318 g taurine 0.06 g ATC: B05BA01
Manufacturer: Bieffe Medital S.p.A.
-
The medicinal product is used as a source of amino acids in parenteral nutrition in children and adolescents.
Form: solution for infusion
Active substance Dosage glycine 2.1 g l-alanine 6.3 g l-arginine 4.1 g l-asparagine acid 4.1 g l-cysteine 1 g l-glutamine 7.1 g l-histidine 2.1 g l-isoleucine 3.1 g l-leucine 7 g l-lysine 5.6 g l-methionine 3.1 g l-phenylalanine 2.7 g l-prolinum 5.6 g l-serine 3.8 g taurine 300 mg l-threonine 3.6 g l-tryptophan 1.4 g l-tyrosine 500 mg l-valine 3.6 g ATC: B05BA01
Manufacturer: Fresenius Kabi AB